Publications by authors named "Ian Rowe"

Claim this Profile
M
MELD 3. and the case for continuous updating in liver allocation.
Ian A Rowe, Juan G Abraldes

JHEP Rep· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessing Drug-mediated Inhibition of Liver Transporter Function with MRI: A First-in-Human Study.
Thazin Min, Marta Tibiletti, Paul D Hockings, Aleksandra Galetin, Ebony Gunwhy, Ian Rowe

Radiology· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimal strategies to prevent disease progression and clinical events in MASLD.
Ian A Rowe

J Hepatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply: A prognostic model in patients with alcohol-associated cirrhosis does exist.
Vincent Haghnejad, Laura Burke, Siham El Ouahabi, Richard Parker, Ian A Rowe

Hepatology· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diabetes mellitus in alcohol-associated liver disease: Prevalence and outcomes.
Ben Ward, Mark Theodoreson, Guruprasad Aithal, Michael Allison, Mayur Brahmania, Ian A Rowe

Hepatol Commun· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Qualitative study explores patient preferences for metabolic dysfunction-associated steatotic liver disease nomenclature.
Katie Williams, Daniel J Cuthbertson, Louise Roper, Ian Rowe, Theresa J Hydes

J Hepatol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Defining Risk in Alcohol-Associated Liver Disease Using the Model for End-Stage Liver Disease.
Richard Parker, Guru Aithal, Michael Allison, Mayur Brahmania, Ewan Forrest, Ian Rowe

Am J Gastroenterol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical Trial: A Multicentre Randomised Controlled Trial of Carvedilol Versus Variceal Band Ligation in Primary Prevention of Variceal Bleeding in Liver Cirrhosis (CALIBRE Trial).
Dhiraj Tripathi, Kelly Handley, Lisa Holden, Zainab Abdali, Sue Jowett, Ian Rowe

Aliment Pharmacol Ther· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HCC-surveillance is associated with improved HCC-related mortality in patients with cirrhosis - a case-control study.
Hannes Hegmar, Bonnie Bengtsson, Sofia Ullman, Ian A Rowe, Per Stål

Scand J Gastroenterol· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply to: Correspondence on 'Plasma exchange does not improve overall survival in patients with acute liver failure in a real world cohort'.
Laura Burke, Ian Rowe, Mansoor Nawaz Bangash, Rajiv Jalan, Joanna Moore

J Hepatol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Plasma exchange does not improve overall survival in patients with acute liver failure in a real-world cohort.
Laura Burke, William Bernal, Tasneem Pirani, Banwari Agarwal, Rajiv Jalan, Ian Rowe

J Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prediction models for liver decompensation in compensated advanced chronic liver disease: A systematic review.
Vincent Haghnejad, Laura Burke, Siham El Ouahabi, Richard Parker, Ian A Rowe

Hepatology· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subgroups of Steatotic Liver Disease Have Distinct Clinical Phenotypes.
Katrina Pekarska, Laura Burke, Ian Rowe, Richard Parker

J Clin Exp Hepatol· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatocellular carcinoma risk scores for non-viral liver disease: A systematic review and meta-analysis.
Laura Burke, Alexander Hinkson, Vincent Haghnejad, Rebecca Jones, Richard Parker, Ian A Rowe

JHEP Rep· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Effectiveness of Hepatocellular Carcinoma Surveillance Strategies in Patients With Compensated Liver Cirrhosis in the United Kingdom.
Osvaldo Ulises Garay, Louisa Elena Ambühl, Thomas G Bird, Eleanor Barnes, William L Irving, Ian A Rowe

Value Health· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A roadmap for clinical trials in MASH-related compensated cirrhosis.
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, Ramón Bataller, Annalisa Berzigotti, Ian A Rowe

Nat Rev Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Author Correction: A roadmap for clinical trials in MASH-related compensated cirrhosis.
Juan M Pericàs, Quentin M Anstee, Salvador Augustin, Ramón Bataller, Annalisa Berzigotti, Ian A Rowe

Nat Rev Gastroenterol Hepatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Liver transplantation for critically ill patients with acute on chronic liver failure: a prospective national programme of waitlist prioritisation.
William Bernal, Rhiannon Taylor, Ian A Rowe, Abhishek Chauhan, Matthew J Armstrong

Lancet Reg Health Eur· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Accurate prediction of all-cause mortality in patients with metabolic dysfunction-associated steatotic liver disease using electronic health records.
Ignat Drozdov, Benjamin Szubert, Ian A Rowe, Timothy J Kendall, Jonathan A Fallowfield

Ann Hepatol· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
British Society of Gastroenterology guidelines for the management of hepatocellular carcinoma in adults.
Abid Suddle, Helen Reeves, Richard Hubner, Aileen Marshall, Ian Rowe

Gut· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Routes to diagnosis for hepatocellular carcinoma patients: predictors and associations with treatment and mortality.
Anya Burton, Jennifer Wilburn, Robert J Driver, David Wallace, Sean McPhail, Ian A Rowe

Br J Cancer· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of recipient age on prioritisation for liver transplantation in the UK: a population-based modelling study.
Anthony Attia, Jamie Webb, Katherine Connor, Chris J C Johnston, Michael Williams, Ian A Rowe

Lancet Healthy Longev· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The future of International Classification of Diseases coding in steatotic liver disease: An expert panel Delphi consensus statement.
Hannes Hagström, Leon A Adams, Alina M Allen, Christopher D Byrne, Yoosoo Chang, Ian A Rowe

Hepatol Commun· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
European Society for Organ Transplantation (ESOT) Consensus Statement on Outcome Measures in Liver Transplantation According to Value-Based Health Care.
Marco Carbone, James Neuberger, Ian Rowe, Wojciech G Polak, Anna Forsberg

Transpl Int· February 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ablative and non-surgical therapies for early and very early hepatocellular carcinoma: a systematic review and network meta-analysis.
Ros Wade, Emily South, Sumayya Anwer, Sahar Sharif-Hurst, Melissa Harden, Ian Rowe

Health Technol Assess· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis